ANI Pharmaceuticals announced that it has entered into separate, privately negotiated agreements with certain holders of its outstanding 3.00% Convertible Senior Notes due 2019. ANI has agreed to repurchase $25M aggregate principal amount of Notes for a total of $26.1M in cash, including accrued but unpaid interest up to but excluding the closing date for the transactions. In connection with the contemplated repurchase of Notes, ANI has also entered into an agreement with the dealer party to certain convertible note hedge transactions related to the Notes to unwind a corresponding portion of such convertible note hedge transactions. ANI has also entered into agreements with such dealer counterparty to unwind certain warrant transactions in amounts corresponding to the portion of the Notes outstanding being repurchased.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.